BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Qi J, Zhu YQ, Huang MF, Yang D. Hypermethylation of CpG island in O6-methylguanine-DNA methyltransferase gene was associated with K-ras G to A mutation in colorectal tumor. World J Gastroenterol 2005; 11(13): 2022-2025 [PMID: 15800999 DOI: 10.3748/wjg.v11.i13.2022]
URL: https://www.wjgnet.com/1007-9327/full/v11/i13/2022.htm
Number Citing Articles
1
Chun Y. Wong, Jorge Martinez, Jian Zhao, Hani Al-Salami, Crispin R. Dass. Development of orally administered insulin-loaded polymeric-oligonucleotide nanoparticles: statistical optimization and physicochemical characterizationDrug Development and Industrial Pharmacy 2020; 46(8): 1238 doi: 10.1080/03639045.2020.1788061
2
Marta Brell, Javier Ibáñez, Avelina Tortosa. O6-Methylguanine-DNA methyltransferase protein expression by immunohistochemistry in brain and non-brain systemic tumours: systematic review and meta-analysis of correlation with methylation-specific polymerase chain reactionBMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-35
3
Jian Qi, You-Qing Zhu, Jun Luo, Wen-Hui Tao. Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumorWorld Journal of Gastroenterology 2006; 12(44): 7113-7117 doi: 10.3748/wjg.v12.i44.7113
4
Sameer Mirza, Gayatri Sharma, Pranav Pandya, Ranju Ralhan. Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agentsMolecular and Cellular Biochemistry 2010; 342(1-2): 101 doi: 10.1007/s11010-010-0473-y
5
Gayatri Sharma, Sameer Mirza, Rajinder Parshad, Anurag Srivastava, Siddartha Datta Gupta, Pranav Pandya, Ranju Ralhan. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patientsLife Sciences 2010; 87(3-4): 83 doi: 10.1016/j.lfs.2010.05.001
6
Shee-Ping Chen, Sheng-Chun Chiu, Chang-Chieh Wu, Shinn-Zong Lin, Jung-Cheng Kang, Yi-Lin Chen, Po-Cheng Lin, Cheng-Yoong Pang, Horng-Jyh Harn. The Association of Methylation in the Promoter of APC and MGMT and the Prognosis of Taiwanese CRC PatientsGenetic Testing and Molecular Biomarkers 2009; 13(1): 67 doi: 10.1089/gtmb.2008.0045
7
Chi‐Chou Huang, Wen‐Pin Chien, Ruey‐Hong Wong, Ya‐Wen Cheng, Meng‐Cheng Chen, Huei Lee. NAT2 fast acetylator genotype and MGMT promoter methylation may contribute to gender difference in K‐RAS mutation occurrence in Taiwanese colorectal cancerEnvironmental and Molecular Mutagenesis 2009; 50(2): 127 doi: 10.1002/em.20444
8
Stephan Stern, Scott McNeil, Anil Patri, Marina Dobrovolskaia. Nanotechnology for Cancer Therapy2006; : 105 doi: 10.1201/9781420006636.ch7
9
Alfonso Dueñas-González, Marcela Lizano, Myrna Candelaria, Lucely Cetina, Claudia Arce, Eduardo Cervera. Epigenetics of cervical cancer. An overview and therapeutic perspectivesMolecular Cancer 2005; 4(1) doi: 10.1186/1476-4598-4-38
10
O. OZALP YUREGIR, E. YURTCU, E. KIZILKILIC, N. E. KOCER, H. OZDOGU, F. I. SAHIN. Detecting methylation patterns of p16, MGMT, DAPK and E‐cadherin genes in multiple myeloma patientsInternational Journal of Laboratory Hematology 2010; 32(2): 142 doi: 10.1111/j.1751-553X.2009.01146.x
11
Isabela Angeli de Lima, Najeh Maissar Khalil, Tania Toyomi Tominaga, Anna Lechanteur, Bruno Sarmento, Rubiana Mara Mainardes. Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acidArtificial Cells, Nanomedicine, and Biotechnology 2018; 46(sup2): 993 doi: 10.1080/21691401.2018.1477788
12
Diego M Marzese, Dave SB Hoon. Emerging technologies for studying DNA methylation for the molecular diagnosis of cancerExpert Review of Molecular Diagnostics 2015; 15(5): 647 doi: 10.1586/14737159.2015.1027194
13
Xiahui Liu, Yingying Zhang, Dongmei Ma, Hao Tang, Liang Tan, Qingji Xie, Shouzhuo Yao. Biocompatible multi-walled carbon nanotube-chitosan–folic acid nanoparticle hybrids as GFP gene delivery materialsColloids and Surfaces B: Biointerfaces 2013; 111: 224 doi: 10.1016/j.colsurfb.2013.06.010
14
Pooneh Mokarram, Mehrdad Asghari Estiar, Hassan Ashktorab. Epigenetics Territory and Cancer2015; : 373 doi: 10.1007/978-94-017-9639-2_13
15
Sally M. Shalaby, Amal S. El-Shal, Lobna A. Abdelaziz, Eman Abd-Elbary, Mostafa M. Khairy. Promoter methylation and expression of DNA repair genes MGMT and ERCC1 in tissue and blood of rectal cancer patientsGene 2018; 644: 66 doi: 10.1016/j.gene.2017.10.056
16
Bio-Targets and Drug Delivery Approaches2016; : 259 doi: 10.1201/9781315370118-12
17
Suphiya Parveen, Sanjeeb K. Sahoo. Polymeric nanoparticles for cancer therapyJournal of Drug Targeting 2008; 16(2): 108 doi: 10.1080/10611860701794353
18
Paul Schlinkert, Eudald Casals, Matthew Boyles, Ulrike Tischler, Eva Hornig, Ngoc Tran, Jiayuan Zhao, Martin Himly, Michael Riediker, Gertie Janneke Oostingh, Victor Puntes, Albert Duschl. The oxidative potential of differently charged silver and gold nanoparticles on three human lung epithelial cell typesJournal of Nanobiotechnology 2015; 13(1) doi: 10.1186/s12951-014-0062-4
19
Alessio Amatu, Andrea Sartore-Bianchi, Catia Moutinho, Alessandro Belotti, Katia Bencardino, Giuseppe Chirico, Andrea Cassingena, Francesca Rusconi, Anna Esposito, Michele Nichelatti, Manel Esteller, Salvatore Siena. Promoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal CancerClinical Cancer Research 2013; 19(8): 2265 doi: 10.1158/1078-0432.CCR-12-3518
20
Jaime Antonio Oliver, Raúl Ortiz, Consolación Melguizo, Pablo Juan Álvarez, Jaime Gómez-Millán, Jose Prados. Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinomaBMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-511
21
Sergio Alonso, Yuichi Dai, Kentaro Yamashita, Shina Horiuchi, Tomoko Dai, Akihiro Matsunaga, Rosa Sánchez-Muñoz, Cristina Bilbao-Sieyro, Juan Carlos Díaz-Chico, Andrei V. Chernov, Alex Y. Strongin, Manuel Perucho. Methylation ofMGMTandADAMTS14in normal colon mucosa: biomarkers of a field defect for cancerization preferentially targeting elder African-AmericansOncotarget 2015; 6(5): 3420 doi: 10.18632/oncotarget.2852
22
Zhipeng Chen, Lu Xiao, Wen Liu, Dan Liu, Yan-Yu Xiao, Jun Chen, Xiao Liu, Wei-Dong Li, Wei Li, Bao-Chang Cai. Novel materials which possess the ability to target liver cellsExpert Opinion on Drug Delivery 2012; 9(6): 649 doi: 10.1517/17425247.2012.679261
23
Chen-guo Zheng, Chun Jin, Le-chi Ye, Nian-zhao Chen, Zong-Jing Chen. Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysisTumor Biology 2015; 36(8): 5839 doi: 10.1007/s13277-015-3254-0
24
F. Bishehsari, M. Mahdavinia, R. Malekzadeh, F. Verginelli, T. Catalano, M. Sotoudeh, V. Bazan, V. Agnese, D.L. Esposito, L. De Lellis, D. Semeraro, G. Colucci, M. Hormazdi, N. Rakhshani, A. Cama, M. Piantelli, S. Iacobelli, A. Russo, R. Mariani-Costantini. Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of originAnnals of Oncology 2006; 17: vii91 doi: 10.1093/annonc/mdl959
25
Lifeng Qi, Zirong Xu. In vivo antitumor activity of chitosan nanoparticlesBioorganic & Medicinal Chemistry Letters 2006; 16(16): 4243 doi: 10.1016/j.bmcl.2006.05.078
26
Khalid A. Alamry, Mahmoud A. Hussein, Youssef O. Al-Ghamdi, Tamer S. Saleh, Abdullah M. Asiri, Alawi M. Alhebshi, George William Weaver. Potential anti-cancer performance of chitosan-based β-ketosulfone derivativesCogent Chemistry 2018; 4(1): 1559435 doi: 10.1080/23312009.2018.1559435
27
Vanessa Deschoolmeester, Marc Baay, Pol Specenier, Filip Lardon, Jan B. Vermorken. A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted TherapyThe Oncologist 2010; 15(7): 699 doi: 10.1634/theoncologist.2010-0025
28
Shee-Ping Chen, Sheng-Chun Chiu, Chang-Chieh Wu, Shinn-Zong Lin, Jung-Cheng Kang, Yi-Lin Chen, Po-Cheng Lin, Cheng-Yoong Pang, Horng-Jyh Harn. The Association of Methylation in the Promoter ofAPCandMGMTand the Prognosis of Taiwanese CRC PatientsGenetic Testing 2009; 0(0): 090108090224061 doi: 10.1089/gte.2008.0045